acetylcysteine has been researched along with tacrolimus in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Koizumi, H; Mano, K; Murata, M; Ohta, K; Yamashita, N | 1 |
| Liu, N; Lynn, WS; Qiang, W; Shen, J; Wong, PK; Yan, M | 1 |
| Bear, MF; Colledge, M; Crozier, RA; Jin, Y; Langeberg, LK; Lu, H; Scott, JD; Snyder, EM; Soderling, JA | 1 |
| Gabryel, B; Małecki, A; Toborek, T | 1 |
| Carrero, JC; Montfort, I; Nequiz, M; Olivos-García, A; Pérez-Tamayo, R; Ramos, E; Tello, E | 1 |
| Essig, M; Gastinel, LN; Lamoureux, F; Marquet, P; Mestre, E; Sauvage, FL | 1 |
| Hong, JM; Moon, JH; Park, SY | 1 |
1 review(s) available for acetylcysteine and tacrolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for acetylcysteine and tacrolimus
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Nuclear factor kappa B mediates interleukin-8 production in eosinophils.
Topics: Acetylcysteine; Cell Nucleus; Cysteine Proteinase Inhibitors; Densitometry; Electrophoresis; Enzyme-Linked Immunosorbent Assay; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunohistochemistry; Immunosuppressive Agents; Interleukin-8; Leupeptins; NF-kappa B; Tacrolimus; Tumor Necrosis Factor-alpha | 1999 |
The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycle Proteins; Cells, Cultured; Dexamethasone; DNA; DNA-Binding Proteins; Female; Flow Cytometry; Free Radical Scavengers; Humans; Immunosuppressive Agents; Lymphocytes; Male; Mice; Mitogens; Oxidation-Reduction; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Spleen; Tacrolimus; Thymidine; Thymus Gland; Tumor Suppressor Proteins | 2001 |
Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression.
Topics: Acetylcysteine; Analysis of Variance; Animals; Animals, Newborn; Blotting, Western; Calcium; Cells, Cultured; Colforsin; Cysteine Proteinase Inhibitors; Disks Large Homolog 4 Protein; Drug Interactions; Electric Stimulation; Embryo, Mammalian; Endocytosis; Epitopes; Excitatory Amino Acid Agonists; Hippocampus; Humans; Immunoglobulin G; Immunohistochemistry; Immunosuppressive Agents; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Kidney; Leupeptins; Membrane Potentials; Membrane Proteins; Mutation; N-Methylaspartate; Nerve Tissue Proteins; Neural Inhibition; Neurons; Nuclear Proteins; Patch-Clamp Techniques; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Rats; Rats, Long-Evans; Receptors, AMPA; Synapses; Synapsins; Tacrolimus; Time Factors; Transfection; Ubiquitin | 2003 |
Immunosuppressive immunophilin ligands attenuate damage in cultured rat astrocytes depleted of glutathione and exposed to simulated ischemia in vitro. Comparison with N-acetylcysteine.
Topics: Acetylcysteine; Animals; Apoptosis; Astrocytes; Benzimidazoles; Brain Ischemia; Cell Separation; Cells, Cultured; Cyclosporine; Fluorescent Dyes; Free Radical Scavengers; Glutathione; Immunophilins; Immunosuppressive Agents; Ligands; Mitochondria; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Tacrolimus; Tetrazolium Salts; Thiazoles | 2005 |
Late experimental amebic liver abscess in hamster is inhibited by cyclosporine and N-acetylcysteine.
Topics: Acetylcysteine; Animals; Antiviral Agents; Cricetinae; Cyclosporine; Entamoeba histolytica; Immunosuppression Therapy; Immunosuppressive Agents; Liver Abscess, Amebic; Sirolimus; Tacrolimus | 2007 |
Quantitative proteomic analysis of cyclosporine-induced toxicity in a human kidney cell line and comparison with tacrolimus.
Topics: Acetylcysteine; Amino Acid Sequence; Basigin; Cell Survival; Cyclophilins; Cyclosporine; Endoplasmic Reticulum Stress; HEK293 Cells; Humans; Kidney; Lipid Peroxidation; Oxidative Stress; Proteomics; Tacrolimus; Up-Regulation | 2011 |
Calcineurin Activation by Prion Protein Induces Neurotoxicity via Mitochondrial Reactive Oxygen Species.
Topics: Acetylcysteine; Apoptosis; Calcineurin; Cell Line, Tumor; Cytosol; Humans; Mitochondria; Peptides; Prion Proteins; Reactive Oxygen Species; Tacrolimus; Up-Regulation | 2021 |